2025 results slightly exceeded expectations due to lower Q4 costs, with strong dividend guidance and a positive start to 2026 as volumes rose 8%. Key risks include PET price inflation, but management expects to meet 2026 targets.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.